Boston Scientific Corporation/ US1011371077 /
| 11/11/2024 6:31:21 PM | Chg. +0.49 | Volume | Bid6:31:29 PM | Ask6:31:29 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 88.74USD | +0.56% | 1.33 mill. Turnover: 82.11 mill. |
88.73Bid Size: 200 | 88.75Ask Size: 300 | 130.85 bill.USD | - | 82.20 |
Assets
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 1,546 | 1,507 | 1,490 | 1,630 | 1,697 | ||||||
| Intangible Assets | 5,950 | 5,606 | 6,194 | 5,883 | 5,837 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | 13,436 | 14,662 | 14,857 | 15,220 | ||||||
| Inventories | 897 | 946 | 1,016 | 955 | 1,078 | ||||||
| Accounts Receivable | - | 1,183 | 1,275 | 1,472 | 1,548 | ||||||
| Cash and Cash Equivalents | 217 | 587 | 319 | 196 | 188 | ||||||
| Current Assets | 3,011 | 3,606 | 3,471 | 3,239 | 3,822 | ||||||
| Total Assets | 16,571 | 17,042 | 18,133 | 18,096 | 19,042 | ||||||
Liabilities
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 246 | 262 | 209 | 447 | 530 | ||||||
| Long-term debt | - | 3,859 | 5,674 | 5,420 | 3,815 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 1,402 | 1,214 | 735 | 18 | 191 | ||||||
| Liabilities | 10,032 | 10,585 | 11,813 | 11,363 | 12,030 | ||||||
| Share Capital | - | 16 | 16 | 16 | 16 | ||||||
| Total Equity | 6,539 | 6,457 | 6,320 | 6,733 | 7,012 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 16,571 | 17,042 | 18,133 | 18,096 | 19,042 | ||||||
Income Statement
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 7,143 | 7,380 | 7,477 | 8,386 | 9,048 | ||||||
| Depreciation (total) | 410 | 438 | 495 | 545 | 565 | ||||||
| Operating Result | 120 | -301 | -327 | 447 | 1,285 | ||||||
| Interest Income | -324 | -216 | -284 | -233 | -229 | ||||||
| Income Before Taxes | -223 | -509 | -650 | 177 | 933 | ||||||
| Income Taxes | -102 | -390 | -411 | -170 | 828 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | -121 | -119 | -239 | 347 | 104 | ||||||
Per Share
Cash Flow
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 1,082 | 1,269 | 600 | 972 | 1,426 | ||||||
| Cash Flow from Investing Activities | -475 | -745 | -2,186 | -887 | -1,010 | ||||||
| Cash Flow from Financing | -596 | -150 | 1,322 | -206 | 110 | ||||||
| Decrease / Increase in Cash | 10 | 370 | -268 | -123 | 530 | ||||||
| Employees | 23,000 | 24,000 | 25,000 | 27,000 | 29,000 | ||||||
